2nd Quarter - Report

FTI GOVERNMENT AFFAIRS for PERRIGO, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Monitor tax reform.

LobbyistCovered position, as disclosed
THOMAS CRAWFORD —
DAVID PATRICK ROBERTSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Dextromethorphan, Pseudoephedrine restriction issues.

LobbyistCovered position, as disclosed
THOMAS CRAWFORD —
DAVID PATRICK ROBERTSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.

LobbyistCovered position, as disclosed
THOMAS CRAWFORD —
JEFFERIES MURRAY —
DAVID PATRICK ROBERTSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 605 (113th), S. 3187 (113th), H.R. 5651 (113th), S. 312 (113th), H.R. 3630 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.